Rayence Co. Ltd Cash Flow Conversion Efficiency
Rayence Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Rayence Co. Ltd (228850) has a cash flow conversion efficiency ratio of 0.009x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.22 Billion ≈ $1.50 Million USD) by net assets (₩242.10 Billion ≈ $164.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Rayence Co. Ltd (2015–2025)
Cash flow conversion efficiency of Rayence Co. Ltd from 2015 to 2025. This chart illustrates how Rayence Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Rayence Co. Ltd stock quote for real-time trading data and today's change.
Rayence Co. Ltd Cash Flow Conversion Ratio Explained
Rayence Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Rayence Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rayence Co. Ltd ranked by their cash flow conversion efficiency. Also see Rayence Co. Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MHC Plantations Bhd
KLSE:5026
|
0.202x |
|
Dual Co Ltd
KO:016740
|
0.062x |
|
Orthex Oyj
HE:ORTHEX
|
0.158x |
|
Electrotherm (India) Limited
NSE:ELECTHERM
|
-1.082x |
|
NAU IB Capital
KQ:293580
|
-0.026x |
|
Resource Alam Indonesia Tbk
JK:KKGI
|
-0.087x |
|
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV
|
-0.149x |
|
SHEPHERD NEAME P. CONS.
F:43Y
|
N/A |
Annual Cash Flow Conversion Efficiency for Rayence Co. Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Rayence Co. Ltd from 2015 to 2025. Review 228850 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩237.37 Billion ≈ $160.86 Million |
₩9.21 Billion ≈ $6.24 Million |
0.039x | -61.79% |
| 2024-12-31 | ₩244.67 Billion ≈ $165.81 Million |
₩24.84 Billion ≈ $16.83 Million |
0.102x | -5.32% |
| 2023-12-31 | ₩240.80 Billion ≈ $163.19 Million |
₩25.82 Billion ≈ $17.50 Million |
0.107x | +45.11% |
| 2022-12-31 | ₩224.75 Billion ≈ $152.31 Million |
₩16.61 Billion ≈ $11.25 Million |
0.074x | -29.22% |
| 2021-12-31 | ₩200.58 Billion ≈ $135.93 Million |
₩20.94 Billion ≈ $14.19 Million |
0.104x | -15.53% |
| 2020-12-31 | ₩188.17 Billion ≈ $127.52 Million |
₩23.25 Billion ≈ $15.76 Million |
0.124x | +154.02% |
| 2019-12-31 | ₩194.30 Billion ≈ $131.67 Million |
₩9.45 Billion ≈ $6.41 Million |
0.049x | -39.82% |
| 2018-12-31 | ₩181.86 Billion ≈ $123.25 Million |
₩14.70 Billion ≈ $9.96 Million |
0.081x | -30.74% |
| 2017-12-31 | ₩176.64 Billion ≈ $119.71 Million |
₩20.62 Billion ≈ $13.97 Million |
0.117x | +130.75% |
| 2016-12-31 | ₩165.42 Billion ≈ $112.10 Million |
₩8.37 Billion ≈ $5.67 Million |
0.051x | -67.47% |
| 2015-12-31 | ₩60.02 Billion ≈ $40.67 Million |
₩9.33 Billion ≈ $6.32 Million |
0.155x | -- |
About Rayence Co. Ltd
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more